Form 13-F position report

* DOLBY LABORATORIES INC

Reported by BAILLIE GIFFORD & CO

DLB CUSIP 25659T107 Manager CIK 0001088875

Reported 0 shares, down 462,473 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 45 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 33867000
2022-03-31 29818000
2022-06-30 36004000
2022-09-30 33940000
2022-12-31 44061824
2023-03-31 58545501
2023-06-30 55976815
2023-09-30 42144840
2023-12-31 40983072
2024-03-31 38741363
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by BAILLIE GIFFORD & CO.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -462,473 (-100.0%) 0 $0 2024-07-25
Q1 2024 Reduced 462,473 -13,079 (-2.8%) 0.03% $38,741,363 2024-05-01
Q4 2023 Reduced 475,552 -56,177 (-10.6%) 0.03% $40,983,072 2024-01-26
Q3 2023 Reduced 531,729 -137,210 (-20.5%) 0.04% $42,144,840 2023-11-13
Q2 2023 Reduced 668,939 -16,445 (-2.4%) 0.05% $55,976,815 2023-07-28
Q1 2023 Added 685,384 +60,748 (9.7%) 0.05% $58,545,501 2023-05-03
Q4 2022 Added 624,636 +103,683 (19.9%) 0.05% $44,061,824 2023-01-24
Q3 2022 Added 520,953 +17,818 (3.5%) 0.03% $33,940,000 2022-10-27
Q2 2022 Added 503,135 +121,923 (32.0%) 0.04% $36,004,000 2022-08-08
Q1 2022 Added 381,212 +25,536 (7.2%) 0.02% $29,818,000 2022-05-05
Q4 2021 Added 355,676 +43,572 (14.0%) 0.02% $33,867,000 2022-01-20
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

461 managers reported * DOLBY LABORATORIES INC for Q2 2024.

Managers reporting * DOLBY LABORATORIES INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 6,604,790 +102,327 0.01% $523,297,512 45 qtrs
MORGAN STANLEY Added 5,869,544 +7,589 0.04% $465,044,271 45 qtrs
BlackRock Inc Reduced 5,788,215 -30,331 0.01% $458,600,307 45 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Reduced 3,079,295 -1,561,778 0.6% $243,972,614 17 qtrs
Ninety One UK Ltd Added 2,344,963 +60,114 0.51% $185,791,419 12 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 2,236,798 -87,446 0.03% $177,221,464 45 qtrs
Clearbridge Investments LLC Reduced 2,001,907 -336,397 0.13% $158,611,120 45 qtrs
STATE STREET CORPORATION Added 1,902,297 +11,923 < 0.01% $150,718,991 45 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 1,475,290 +105,195 0.01% $117,312,420 45 qtrs
DISCIPLINED GROWTH INVESTORS INC MN Added 1,402,623 +10,852 2.09% $111,129,820 45 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
July 25, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.